Next report date
Report period
Q1 2024
EPS estimate
−0.23USD
Revenue estimate
25.89 MUSD
−160.28 MUSD
27.96 MUSD
70.65 M
Om Avadel Pharmaceuticals plc
Sektor
Bransch
VD
Gregory J. Divis
Webbplats
Huvudkvarter
Dublin
Employees (FY)
154
Grundat
2015
ISIN
IE00BDGMC594
FIGI
BBG00FPFX9W4
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
